Completed PHASE4 INTERVENTIONAL NCT00209768

Use of In-Line Filtration in Critically Ill Children

Randomised, Prospective Study of the Use of In-Line Filtration on the Reduction of Complication Rate in Critically Ill Children

Sponsor: B. Braun Melsungen AG

Conditions Critical Illness

Interventions Filter: NOE96E, ELD96E, NLF1E, TNA1E

Updated 7 times since 2017 Last updated: Nov 28, 2008 Started: Feb 28, 2005 Primary completion: Sep 30, 2008 Completion: Sep 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00209768, this PHASE4 trial focuses on Critical Illness and remains completed. Sponsored by B. Braun Melsungen AG, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Apr 2019 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Jun 2018 — Apr 2019 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

B. Braun Melsungen AG
Hannover Medical School
Pall Corporation

Data source: Hannover Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hanover, Germany